-
公开(公告)号：US12163153B2
公开(公告)日：2024-12-10
申请号：US16857394
申请日：2020-04-24
Applicant: ALLOGENE THERAPEUTICS, INC.
IPC: C12N5/00 , A61K35/17 , C12N5/0783
Abstract: Described herein are improved media for culturing immune cells, and methods of use thereof. In particular, cell growth media described herein are particularly suitable for T-cell expansion, which can be used for manufacture of cells useful in adoptive cell therapies, including therapies using chimeric antigen receptors (e.g., CAR-T cell therapy).
Search Results
1
records
(took 0.013 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
